These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 11437358

  • 1. Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells.
    Waki M, Inaba M, Hiura Y, Nagasaki T, Imanishi Y, Ishimura E, Otani S, Nishizawa Y.
    Arch Biochem Biophys; 2001 Jul 15; 391(2):265-70. PubMed ID: 11437358
    [Abstract] [Full Text] [Related]

  • 2. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T, Hino M, Inaba M, Nishizawa Y, Morii H, Otani S.
    Arch Biochem Biophys; 1997 Jul 15; 343(2):181-7. PubMed ID: 9224728
    [Abstract] [Full Text] [Related]

  • 3. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
    Inaba M, Okuno S, Koyama H, Nishizawa Y, Morii H.
    Arch Biochem Biophys; 1992 Feb 14; 293(1):181-6. PubMed ID: 1309983
    [Abstract] [Full Text] [Related]

  • 4. Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid.
    Li J, Finch RA, Sartorelli AC.
    Exp Cell Res; 1999 Jun 15; 249(2):279-90. PubMed ID: 10366427
    [Abstract] [Full Text] [Related]

  • 5. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM, Schwartz GG, Woodruff R, Cramer SD.
    Cancer Epidemiol Biomarkers Prev; 2000 Mar 15; 9(3):265-70. PubMed ID: 10750664
    [Abstract] [Full Text] [Related]

  • 6. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.
    Hosoi J, Abe E, Suda T, Kuroki T.
    Cancer Res; 1985 Apr 15; 45(4):1474-8. PubMed ID: 2983883
    [Abstract] [Full Text] [Related]

  • 7. Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.
    Sasaki K, Chida K, Hashiba H, Kamata N, Abe E, Suda T, Kuroki T.
    Cancer Res; 1986 Feb 15; 46(2):604-10. PubMed ID: 3000580
    [Abstract] [Full Text] [Related]

  • 8. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
    Okuno S, Inaba M, Nishizawa Y, Morii H.
    Miner Electrolyte Metab; 1995 Feb 15; 21(1-3):211-6. PubMed ID: 7565452
    [Abstract] [Full Text] [Related]

  • 9. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J.
    Anticancer Res; 2009 Sep 15; 29(9):3647-58. PubMed ID: 19667161
    [Abstract] [Full Text] [Related]

  • 10. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R, Asplin JR, Lindeman C, Favus MJ, Bai S, Coe FL.
    Cell Immunol; 2004 Sep 15; 232(1-2):137-43. PubMed ID: 15876428
    [Abstract] [Full Text] [Related]

  • 11. 1,25-Dihydroxyvitamin D3 enhances cytosolic free calcium in HL-60 cells.
    Barnea E, Levy R, Zimlichman R, Shany S.
    Exp Hematol; 1990 Dec 15; 18(11):1147-51. PubMed ID: 2226676
    [Abstract] [Full Text] [Related]

  • 12. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y, Knutson JC, Bishop C, Shany S.
    Anticancer Res; 1998 Dec 15; 18(3A):1769-75. PubMed ID: 9673403
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
    Kong J, Li YC.
    Am J Physiol Endocrinol Metab; 2006 May 15; 290(5):E916-24. PubMed ID: 16368784
    [Abstract] [Full Text] [Related]

  • 14. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
    Seifert M, Rech M, Meineke V, Tilgen W, Reichrath J.
    J Steroid Biochem Mol Biol; 2004 May 15; 89-90(1-5):375-9. PubMed ID: 15225804
    [Abstract] [Full Text] [Related]

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 15; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 16. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H, Sugita A, Uchiyama Y, Katagiri N, Okazaki M, Ogata E, Ikeda K.
    J Clin Invest; 2006 Feb 15; 116(2):528-35. PubMed ID: 16424941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 1,25-Dihydroxyvitamin D3 decreases expression of HLA class II molecules in a melanoma cell line.
    Carrington MN, Tharp-Hiltbold B, Knoth J, Ward FE.
    J Immunol; 1988 Jun 01; 140(11):4013-8. PubMed ID: 3372995
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA, Rossi AM, Picotto G, Benassati S, Boland RL.
    J Cell Biochem; 2004 Oct 01; 93(2):384-97. PubMed ID: 15368364
    [Abstract] [Full Text] [Related]

  • 20. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.
    Abe J, Moriya Y, Saito M, Sugawara Y, Suda T, Nishii Y.
    Cancer Res; 1986 Dec 01; 46(12 Pt 1):6316-21. PubMed ID: 3490908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.